Monday, January 17, 2022


Godrej & Boyce to strengthen vaccine cold chain

Medical freezers, which maintain 20°C are also being deployed for diluents and ice packs needed for the last mile delivery in the Covid vaccination drive.

Bharat Biotech, Ocugen ink pact for commercialisation of Covaxin in US

Under the terms of the agreement, Ocugen will have the US rights to the vaccine candidate and will be responsible for clinical development, regulatory approval (including emergency use authorisation (EUA)) and commercialisation for the US market.

Rs 35,000 cr budgeted for COVID-19 vaccination expenditure in FY22

India had earlier in January approved two vaccines -- Oxford's Covishield manufactured by SII and Bharat Biotech's Covaxin -- for restricted emergency use.

Covaxin has ability to neutralise UK strain of COVID-19: Review report

Covaxin is India's totally indigenous COVID-19 vaccine developed in collaboration with the Indian Council of Medical Research and National Institute of Virology.

Take precautions before vaccine, allergy patients told

People with recent history of allergic anaphylaxis should compulsorily seek an allergist or immunologist opinion before getting vaccinated

13,000 volunteers given 2nd dose of Covaxin: Bharat Biotech

This is India's first and only phase-3 efficacy study for a Covid-19 vaccine, and the largest phase-3 efficacy trial ever conducted for any vaccine in the country.

Letter of Comfort given to Bharat Biotech

The company was given a fresh letter of comfort recently for supplying another 45 lakh doses of Covaxin. The doses will be dispatched as when the Ministry places orders with the company

Vaccination: Senior doctors lead from the front in Hyderabad

Get vaccinated against Covid despite having pre-existing medical conditions like diabetes and hypertension

1.91 L inoculated in India on Day 1, no post-inoculation hospitalisation

Giving an update on Covid vaccination, the health ministry said 3,352 vaccination sessions were held and 1,91,181 beneficiaries vaccinated on Saturday

Bharat Biotech to pay compensation if Covaxin causes side effects

According to an industry expert, the company is liable to pay compensation to people in case of serious side effects caused by the vaccine administered while in the clinical trial mode

290 get covid-19 vaccine in erstwhile Khammam on first day

Transport Minister Puvvada Ajay Kumar along with MP Nama Nageswar Rao has formally launched the vaccination programme at the District Hospital.

Watch: Covid-19 vaccination drive commences in Telangana

Krishnamma, a sanitation worker at Gandhi Hospital was the first person to receive the Covid vaccine in Telangana.

Delhi’s RML hospital docs apprehensive about Covaxin, want Covishield

The residents are a bit apprehensive about the lack of complete trial in case of Covaxin and might not participate in huge numbers thus defeating the purpose of vaccination, wrote the doctors

Bhutan PM congratulates Modi on ‘landmark’ Covid vaccination drive

Addressing the country digitally, the Prime Minister said that India managed to make two 'Made-in-India' vaccines in a very short period which usually takes years.

All you need to know about India’s 2 Covid vaccines

So far, the government has procured 1.1 crore Covishield and 55 lakh Covaxin vaccines at a cost of Rs 200 and Rs 206 per dose, respectively.

Latest News

- Advertisement -